Report cover image

Global Medical Grade Polycaprolactone (PCL) Market Growth 2025-2031

Published Aug 07, 2025
Length 87 Pages
SKU # LPI20289099

Description

The global Medical Grade Polycaprolactone (PCL) market size is predicted to grow from US$ 45.9 million in 2025 to US$ 75.9 million in 2031; it is expected to grow at a CAGR of 8.7% from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Polycaprolactone (PCL) is a long-term biodegradable polyester with a low melting point of around 60°C and a glass transition temperature of about −60°C. PCL is prepared by ring-opening polymerization of ε-caprolactone and is FDA approved for drug delivery devices and as adhesion barriers. PCL is highly soluble in chlorinated hydrocarbons and can be used for thermal processing like extrusion, fiber spinning, injection molding and 3D-printing.

As a biodegradable polyester material, medical-grade polycaprolactone (PCL) has shown broad application prospects in the medical field due to its excellent biocompatibility, controllable degradability and mechanical properties.

In the global medical-grade PCL market, Ingevity, Daicel and Hunan Juren occupy the main market share. The core applications of medical-grade PCL include drug sustained-release systems, tissue engineering scaffolds, medical beauty regeneration materials and medical consumables (radiotherapy positioning mask), etc. The technical development direction focuses on personalized medicine and 3D printing (such as implantable PCL microspheres), composite biomaterials (such as PCL and hydroxyapatite composite scaffolds to shorten bone repair time by 30%), intelligence (pH-sensitive PCL to achieve precise drug release) and green manufacturing.

LP Information, Inc. (LPI) ' newest research report, the “Medical Grade Polycaprolactone (PCL) Industry Forecast” looks at past sales and reviews total world Medical Grade Polycaprolactone (PCL) sales in 2024, providing a comprehensive analysis by region and market sector of projected Medical Grade Polycaprolactone (PCL) sales for 2025 through 2031. With Medical Grade Polycaprolactone (PCL) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Medical Grade Polycaprolactone (PCL) industry.

This Insight Report provides a comprehensive analysis of the global Medical Grade Polycaprolactone (PCL) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Medical Grade Polycaprolactone (PCL) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Medical Grade Polycaprolactone (PCL) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Medical Grade Polycaprolactone (PCL) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Medical Grade Polycaprolactone (PCL).

This report presents a comprehensive overview, market shares, and growth opportunities of Medical Grade Polycaprolactone (PCL) market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Ordinary Polycaprolactone
Polycaprolactone Microspheres

Segmentation by Application:
Medical Device
Medical Beauty
Drug Sustained Release
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Ingevity
Daicel
Evonik
Corbion
Hunan Juren Chemical Hitechnology
eSUNMED
Shenzhen Polymtek Biomaterial
Sinopec Hunan Petrochemical
Weibo (Shenzhen)

Key Questions Addressed in this Report

What is the 10-year outlook for the global Medical Grade Polycaprolactone (PCL) market?

What factors are driving Medical Grade Polycaprolactone (PCL) market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Medical Grade Polycaprolactone (PCL) market opportunities vary by end market size?

How does Medical Grade Polycaprolactone (PCL) break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.

Table of Contents

87 Pages
*This is a tentative TOC and the final deliverable is subject to change.*
1 Scope of the Report
2 Executive Summary
3 Global by Company
4 World Historic Review for Medical Grade Polycaprolactone (PCL) by Geographic Region
5 Americas
6 APAC
7 Europe
8 Middle East & Africa
9 Market Drivers, Challenges and Trends
10 Manufacturing Cost Structure Analysis
11 Marketing, Distributors and Customer
12 World Forecast Review for Medical Grade Polycaprolactone (PCL) by Geographic Region
13 Key Players Analysis
14 Research Findings and Conclusion
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.